Morgan Stanley Clear Point Neuro, Inc. Transaction History

Morgan Stanley

$1.59 Trillion
Q3 2025

A detailed history of Morgan Stanley transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Morgan Stanley holds 235,281 shares of CLPT stock, worth $3.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

235,281

Previous 332,323 29.2%

Holding current value

$3.64 Million

Previous $3.97 Million 29.22%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$10.0 - $21.79 $970,420 - $2.11 Million	-97,042 Reduced 29.2%	235,281 $5.13 Million
Q2 2025 Aug 15, 2025	BUY	$10.51 - $14.71 $1.83 Million - $2.56 Million	174,353 Added 110.37%	332,323 $3.97 Million
Q1 2025 May 15, 2025	BUY	$11.89 - $18.8 $875,472 - $1.38 Million	73,631 Added 87.3%	157,970 $1.88 Million
Q4 2024 Feb 14, 2025	BUY	$10.74 - $16.68 $402,878 - $625,700	37,512 Added 80.11%	84,339 $1.3 Million
Q3 2024 May 14, 2025	SELL	$5.3 - $13.18 $229,871 - $571,642	-43,372 Reduced 48.08%	46,827 $524,000

Q3 2024 Nov 14, 2024	SELL	$5.3 - $13.18 $229,871 - $571,642	-43,372 Reduced 48.08%	46,827 $524,000
Q2 2024 May 14, 2025	BUY	$5.25 - $6.73 $30,765 - $39,437	5,860 Added 6.95%	90,199 $486,000
Q2 2024 Oct 17, 2024	SELL	$5.25 - $6.73 $334,698 - $429,050	-63,752 Reduced 41.41%	90,199 $486,000
Q2 2024 Aug 14, 2024	SELL	$5.25 - $6.73 $334,698 - $429,050	-63,752 Reduced 41.41%	90,199 $486,000
Q1 2024 Oct 17, 2024	BUY	$6.03 - $7.86 $384,424 - $501,090	63,752 Added 70.68%	153,951 $1.05 Million
Q1 2024 Aug 16, 2024	SELL	$6.03 - $7.86 $48,469 - $63,178	-8,038 Reduced 4.96%	153,951 $1.05 Million
Q1 2024 May 15, 2024	SELL	$6.03 - $7.86 $48,469 - $63,178	-8,038 Reduced 4.96%	153,951 $1.05 Million
Q4 2023 Aug 16, 2024	BUY	$4.46 - $7.07 $320,183 - $507,555	71,790 Added 79.59%	161,989 $1.1 Million
Q4 2023 Feb 13, 2024	BUY	$4.46 - $7.07 $193,095 - $306,095	43,295 Added 36.48%	161,989 $1.1 Million
Q3 2023 Nov 15, 2023	BUY	$5.01 - $7.09 $246,271 - $348,516	49,156 Added 70.69%	118,694 $594,000
Q2 2023 Aug 14, 2023	SELL	$6.54 - $10.58 $168,751 - $272,995	-25,803 Reduced 27.06%	69,538 $503,000
Q1 2023 May 15, 2023	BUY	$7.33 - $10.63 $12,856 - $18,645	1,754 Added 1.87%	95,341 $804,000
Q4 2022 Feb 14, 2023	SELL	$7.7 - $11.21 $77,592 - $112,963	-10,077 Reduced 9.72%	93,587 $792,000
Q3 2022 Nov 14, 2022	SELL	$9.82 - $16.49 $236,141 - $396,535	-24,047 Reduced 18.83%	103,664 $1.07 Million
Q2 2022 Oct 27, 2022	SELL	$7.09 - $13.65 $347,417 - $668,863	-49,001 Reduced 27.73%	127,711 $1.67 Million
Q2 2022 Aug 15, 2022	SELL	$7.09 - $13.65 $347,417 - $668,863	-49,001 Reduced 27.73%	127,711 $1.67 Million
Q1 2022 Oct 27, 2022	BUY	$7.8 - $11.6 $382,207 - $568,411	49,001 Added 38.37%	176,712 $1.84 Million
Q1 2022 May 13, 2022	BUY	$7.8 - $11.6 $393,244 - $584,825	50,416 Added 39.92%	176,712 $1.84 Million
Q4 2021 Feb 14, 2022	BUY	$11.08 - $18.86 $1.26 Million - $2.14 Million	113,360 Added 876.31%	126,296 $1.42 Million
Q3 2021 Nov 15, 2021	BUY	$16.58 - $22.25 $214,478 - $287,826	12,936 New	12,936 $230,000

Others Institutions Holding CLPT

# of Institutions

114

Shares Held

8.38M

Call Options Held

437K

Put Options Held

199K

View Full List

About ClearPoint Neuro, Inc.

Ticker CLPT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,488,300
Market Cap $379M
Description
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...

More about CLPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account